Forte Biosciences (FBRX) EPS (Basic) (2016 - 2026)
Forte Biosciences (FBRX) posted quarterly EPS (Basic) of -$1.24 for Q1 2026, up 9.64% year-over-year from -$1.13 in Q1 2025, and up 25.8% quarter-over-quarter from -$1.67 in Q4 2025.
Forte Biosciences (FBRX) EPS (Basic) (2016 - 2026) Analysis & Trends
Forte Biosciences (FBRX) has reported EPS (Basic) for 11 consecutive years, with -$1.24 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 9.64% year-over-year to -$1.24; the TTM figure through Mar 2026 stood at -$6.01 (down 53.56% YoY), while the FY2025 annual figure was -$5.0, down 606.3% from the prior year.
- EPS (Basic) advanced to -$1.24 in Q1 2026 per FBRX's latest filing, from -$1.67 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$1.24 in Q1 2026 and bottomed at -$10.83 in Q2 2023.
- Historically, EPS (Basic) has averaged -$4.7 across 5 years, with a median of -$4.69 in 2024.
- On a YoY basis, EPS (Basic) climbed as much as 89.68% in 2022 and fell as far as 8590.11% in 2022.
- Forte Biosciences' EPS (Basic) stood at -$7.2 in 2022, then gained by 29.46% to -$5.08 in 2023, then soared by 49.79% to -$2.55 in 2024, then jumped by 34.38% to -$1.67 in 2025, then climbed by 25.8% to -$1.24 in 2026.
- Business Quant data shows FBRX's EPS (Basic) at -$1.24 in Q1 2026, -$1.67 in Q4 2025, and -$2.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Forte Biosciences | 1.63 Bn | 1.28 Bn | - | -0.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.31 |
| Mar 31, 2026 | -1.24 |
| Dec 31, 2025 | -1.67 |
| Sep 30, 2025 | -2.01 |
| Jun 30, 2025 | -2.10 |
| Mar 31, 2025 | -1.37 |
| Dec 31, 2024 | -2.55 |
| Sep 30, 2024 | -4.69 |
| Jun 30, 2024 | -6.96 |
| Mar 31, 2024 | -4.25 |
| Dec 31, 2023 | -5.08 |
| Sep 30, 2023 | -6.75 |
| Jun 30, 2023 | -10.83 |
| Mar 31, 2023 | -8.24 |
| Dec 31, 2022 | -7.20 |
| Sep 30, 2022 | -4.65 |
| Jun 30, 2022 | -5.48 |
| Mar 31, 2022 | -4.77 |
| Dec 31, 2021 | -7.01 |
| Sep 30, 2021 | -15.33 |